CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Magnetic Capsule Endoscopy

Defines coverage and medical necessity stance for magnetically controlled capsule endoscopy (CE) for evaluation of gastrointestinal complaints for Blue Cross Blue Shield - Rhode Island members.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMagnetic Capsule Endoscopy

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateJun 1, 2022

Next Review DateN/A

Key ActionVerify member benefits and contract-specific coverage before scheduling, since coverage may vary and prior authorization is listed as not applicable.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1CPT code listed

2020FDA approval year

Not medically necessaryCommercial stance

Not coveredMedicare Advantage

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Medicare Advantage: Magnetic capsule endoscopy is not covered for the evaluation of individuals with unexplained upper abdominal complaints and all other indications; evidence is insufficient to determine that the technology results in an improvement in the net health outcome.

[[chunk 4]]

Commercial Products: Magnetic capsule endoscopy is considered not medically necessary for the evaluation of individuals with unexplained upper abdominal complaints and all other indications; the evidence is insufficient to determine that the technology results in an improvement in the net health outcome.

[[chunk 5]]

Device-specific contraindications must be considered before scheduling magnetic capsule endoscopy. Contraindicated conditions include known gastrointestinal obstruction, stenosis, fistula, or dysphagia. Other exclusions include patients with implanted electronic medical devices such as cardiac pacemakers, pregnant patients, individuals younger than 22 years of age, and certain body mass index limitations as specified for the system. Verify patient suitability against these contraindications to avoid device-related complications or failed procedures.

For Commercial Products, magnetic capsule endoscopy is considered not medically necessary for the evaluation of individuals with unexplained upper abdominal complaints and for all other indications; available evidence is insufficient to demonstrate an improvement in net health outcome. Benefits and coverage details may vary by group or contract, so providers should verify the member's Benefit Booklet or Evidence of Coverage before scheduling. Claims for these indications may be denied if the service is determined to be not medically necessary under the member's plan.

Billing and Codes

Covered CPT Codes (listed)CPT

0651T

Magnetically controlled capsule endoscopy, esophagus through stomach, including intraprocedural positioning of capsule, with interpretation and report

Not covered / Not medically necessaryCPTNot Covered

0651T

Listed as not covered for Medicare Advantage and not medically necessary for Commercial Products

Provider Requirements & Billing Notes

Prior Authorization

Prior authorization is not applicable for this service. Verify eligibility and any plan-specific requirements prior to scheduling.

Check member's benefits for service limits or exclusions.

Step Therapy

No step therapy requirements are specified for magnetic capsule endoscopy. Providers should still confirm any plan-specific clinical pathway requirements during benefit verification.

Documentation Required

Benefit Verification

Benefits and coverage may vary between groups and contracts. Refer to the member's Benefit Booklet, Evidence of Coverage, or Subscriber Agreement for applicable benefits, limits, and exclusions before providing services.

Confirm member-specific coverage, including whether the service is considered not medically necessary or not covered under the plan.

Denial Risk

Coverage Denial Risk

Coverage denial risk: For Medicare Advantage, magnetic capsule endoscopy is not covered for evaluation of unexplained upper abdominal complaints and all other indications; the evidence is insufficient to demonstrate improved net health outcome. For commercial products, the service is considered not medically necessary for those indications. Submit documentation supporting medical necessity if pursuing coverage.

Include clinical rationale and relevant diagnostic findings when submitting claims.
Be aware that lack of supporting documentation may result in denial as not medically necessary.

Definitions & Contraindications

Magnetic capsule endoscopy (magnetic CE) — definition and device description

TermMagnetic capsule endoscopy (magnetic CE)

Device descriptionAn ingestible single-use capsule containing a camera that wirelessly captures images as it traverses the GI tract, paired with a physician‑operated console that magnetically maneuvers and positions the capsule for visualization of the esophagus and stomach.

Procedure characteristicsNoninvasive, typically does not require sedation, procedural time ~15–20 minutes; capsule is excreted (average passage ~24 hours, may take up to 2 weeks).

Contraindications — device and patient limitations

Known GI tract contraindicationsGastrointestinal obstruction, stenosis, or fistula — device use is contraindicated.

Swallowing-relatedDysphagia — inability to safely swallow the capsule is a contraindication.

Implanted electronic devicesPresence of cardiac pacemakers or other implantable electronic medical devices — contraindicated.

PregnancyPregnant women are listed as contraindicated for use of the device.

Age limitPatients younger than 22 years of age are contraindicated.

Body mass indexCertain BMI limitations are noted (document cites BMI 238 [sic] as a specified limit).

Background

Magnetic capsule endoscopy is a noninvasive diagnostic technique in which a patient swallows a single-use capsule that contains a camera; images are captured wirelessly and viewed on a physician-operated console. A magnetically maneuvered system (e.g., NaviCam) enables external control of the capsule to position it within the esophagus and stomach during the procedure, facilitating visualization without sedation. The procedure typically requires approximately 15–20 minutes, and the capsule usually exits the body within about 24 hours on average, though passage may take up to two weeks.